Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797322 | 0.89 | TSHR (0.42) | TSHRSMN1; SMN2ALDH1A1RAB9APKM | |
| SCHEMBL7791065 | 0.84 | TSHR (0.47) | TSHRSMN1; SMN2ALDH1A1RAB9APKM | |
| SCHEMBL7799308 | 0.81 | TSHR (0.47) | TSHRALDH1A1 | |
| SCHEMBL7797340 | 0.78 | SMN1; SMN2 (0.54) | TSHRSMN1; SMN2ALDH1A1PKMHSD17B10 | |
| SCHEMBL7797307 | 0.75 | SMN1; SMN2 (0.51) | TSHRSMN1; SMN2ALDH1A1PKMHSD17B10 | |
| SCHEMBL160208 | 0.75 | TSHR (0.73) | TSHRSMN1; SMN2ALDH1A1THRB | |
| SCHEMBL17530065 | 0.75 | TSHR (0.40) | TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL14299952 | 0.75 | TSHR (0.46) | TSHRALDH1A1THRB | |
| SCHEMBL18315203 | 0.75 | ALDH1A1 (0.44) | TSHRSMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL7797327 | 0.74 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1PKMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1164125-A1 | ADAMANTANE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Daicel Chemical Industries, Ltd. (JP) | 2001-12-19 | — | — | EP | disclosed |